A RAPID METHOD FOR MEASUREMENT OF THE SUSCEPTIBILITY TO OXIDATION OF LOW-DENSITY-LIPOPROTEIN

被引:80
作者
MCDOWELL, IFW [1 ]
MCENENY, J [1 ]
TRIMBLE, ER [1 ]
机构
[1] QUEENS UNIV BELFAST,INST CLIN SCI,DEPT CLIN BIOCHEM,BELFAST BT12 6BJ,ANTRIM,NORTH IRELAND
关键词
ATHEROSCLEROSIS; ANTIOXIDANTS; PROBUCOL; LIPID PEROXIDATION;
D O I
10.1177/000456329503200206
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Oxidation of low-density lipoprotein (LDL) may be important in the pathogenesis of atherosclerosis. We describe a method which measures the oxidation resistance of LDL isolated by a rapid procedure without added antioxidants. LDL was isolated from heparinized plasma by density gradient ultracentrifugation and desalted by gel filtration. The protein concentration was standardized to 50 mg/L and oxidation was promoted by copper (2 mu mol/L) at 37 degrees C. The total sample preparation time was 2.5 h. Conjugated diene production was monitored at lambda = 234 nm with computation of the lag time. LDL oxidation was inhibited by EDTA but not heparin. Albumin inhibited LDL oxidation but only in concentrations greater than 50 mg/L. LDL was stable in frozen plasma (- 70 degrees C) for 10 weeks, but unstable in the isolated and desalted state. The lag time for LDL from patients treated with the antioxidant probucol was markedly prolonged compared to normal subjects.
引用
收藏
页码:167 / 174
页数:8
相关论文
共 16 条
[1]  
CHUNG BH, 1986, METHOD ENZYMOL, V128, P181
[2]  
COMINACINI L, 1991, J LIPID RES, V32, P349
[3]   EFFECT OF LOW-DOSE PROBUCOL THERAPY ON LDL OXIDATION AND THE PLASMA-LIPOPROTEIN PROFILE IN MALE-VOLUNTEERS [J].
CRISTOL, LS ;
JIALAL, I ;
GRUNDY, SM .
ATHEROSCLEROSIS, 1992, 97 (01) :11-20
[4]  
ELSAADANI M, 1989, J LIPID RES, V30, P627
[5]   CONTINUOUS MONITORING OF INVITRO OXIDATION OF HUMAN LOW-DENSITY LIPOPROTEIN [J].
ESTERBAUER, H ;
STRIEGL, G ;
PUHL, H ;
ROTHENEDER, M .
FREE RADICAL RESEARCH COMMUNICATIONS, 1989, 6 (01) :67-75
[6]   ALBUMIN - AN IMPORTANT EXTRACELLULAR ANTIOXIDANT [J].
HALLIWELL, B .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (04) :569-571
[7]  
HALLIWELL H, 1992, ARCH BIOCHEM BIOPHYS, V280, P1
[8]   PHYSIOLOGICAL LEVELS OF ASCORBATE INHIBIT THE OXIDATIVE MODIFICATION OF LOW-DENSITY-LIPOPROTEIN [J].
JIALAL, I ;
VEGA, GL ;
GRUNDY, SM .
ATHEROSCLEROSIS, 1990, 82 (03) :185-191
[9]  
KLEINVELD HA, 1992, CLIN CHEM, V38, P2066
[10]  
LEAKE DS, 1993, BRIT HEART J, V69, P476